WebMay 7, 2024 · BMY earnings call for the period ending March 31, 2024. Image source: The Motley Fool. Bristol-Myers Squibb Co ( BMY 1.63%) Q1 2024 Earnings Call. May 7, 2024, 8:30 a.m. ET. WebApr 24, 2024 · Bristol-Myers Squibb (BMY) Q1 Earnings and Revenues Top Estimates. Zacks Investment Research • 04/25/19. AbbVie, Bristol Earnings Top Q1 Views ... What To Expect From Bristol-Myers Squibb In Q1? Forbes • 04/24/19. Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain. 24/7 Wall Street • 04/24/19. Kidney …
Bristol Myers Squibb Q1 2024 Results Conference Call
WebApr 29, 2024 · The following slide deck was published by Bristol-Myers Squibb Company in conjunction with their 2024 Q1 earnings call. Seeking Alpha - Go to Homepage Entering text into the input field will ... WebApr 29, 2024 · Bristol Myers, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $11.07 billion for the quarter ended March 2024, missing the Zacks Consensus Estimate by... geopak cross section annotation
Bristol-Myers Squibb Co. Analysis of Profitability Ratios (Q)
WebApr 28, 2024 · BMS’ Q1 2024 adjusted earnings per share is expected to be $1.95 per Trefis analysis, slightly above the consensus estimate of $1.91. The company’s adjusted … WebApr 29, 2024 · Net earnings attributable to Bristol Myers Squibb was $2.0 billion, or $0.89 per share, in the first quarter, compared to net loss of $775 million, or $0.34 per share, … Web2 GAAP and non-GAAP earnings per share include the net impact of ($0.10) from Acquired IPRD & licensing income incurred in Q1 2024 and an additional ($0.11) due to the buyout of future royalty obligation related to mavacamten that occurred in April 2024. geopak make input file command